Review: Virtual Reality Distracts From Pain of Medical Procedures

Share this content:
Review: Virtual Reality Distracts From Pain of Medical Procedures
Review: Virtual Reality Distracts From Pain of Medical Procedures

THURSDAY, March 15, 2018 (HealthDay News) -- Virtual reality (VR) appears to be an effective distraction intervention to relieve pain and distress during various medical procedures, according to a review published online Feb. 26 in The Clinical Journal of Pain.

Paola Indovina, Ph.D., from the Institute for High Performance Computing and Networking, ICAR-CNR, in Naples, Italy, and colleagues conducted a literature review of clinical trials to examine the utility of VR as a distraction intervention to alleviate pain and distress during different medical procedures. These included burn injury treatment, chemotherapy, surgery, dental treatments, and other diagnostic and therapeutic procedures.

The researchers found that VR was effective for reducing procedural pain, even in patients subjected to extremely painful procedures, such as those with burn injuries undergoing wound care and physical therapy. In different settings, including during chemotherapy, VR seemed to reduce cancer-related symptoms. Side effects were mild and infrequent.

"Despite these promising results, future long-term randomized controlled trials with larger sample sizes and evaluating not only self-report measures but also physiological variables are needed," the authors write. "Further studies are also required both to establish predictive factors to select patients who can benefit from VR distraction and to design hardware/software systems tailored to the specific needs of different patients and able to provide the greatest distraction at the lowest cost."

Abstract/Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

Cap'n Crunch Cereal Recalled Due to Salmonella Scare

Cap'n Crunch Cereal Recalled Due to <i>Salmonella</i> Scare

No illnesses related to the products have been reported to date

FDA Approves First-Line Tx for Peripheral T-Cell Lymphoma

FDA Approves First-Line Tx for Peripheral T-Cell Lymphoma

Adcetris approved in combination with chemo to treat systemic anaplastic large cell lymphoma

FDA Warns Against Giving Honey-Filled Pacifiers to Infants

FDA Warns Against Giving Honey-Filled Pacifiers to Infants

Four infants in Texas hospitalized with botulism after using pacifiers containing honey

is free, fast, and customized just for you!




Already a member?

Sign In Now »